Original Research
Published on 26 Feb 2025
Low-level neurostimulation of the renal nerves as a potential therapeutic strategy for hypertension treatment
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1529844
Type at least 3 characters
2,323 articles
Articles
Original Research
Accepted on 04 Feb 2025
Acetate and propionate as a novel method for cognitive dysfunction and anxiety symptoms in delayed encephalopathy after acute carbon monoxide poisoning rat
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1520988
Mini Review
Published on 26 Feb 2025
Innovative therapeutic strategies using ADHD medications tailored to the behavioral characteristics of patients with chronic pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1500313
- 167 views
Review
Accepted on 25 Feb 2025
The critical role of Sirt1 in ischemic stroke
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1425560
Original Research
Published on 25 Feb 2025
Exploring the potential anti-senescence effects of soybean-derived peptide Soymetide in mice hippocampal neurons via the Wnt/β-catenin pathway
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1510337
- 221 views
Original Research
Published on 25 Feb 2025
Neuroprotective effects of ethanol extraction from Rubia yunnanensis Diels on chronic cerebral hypoperfusion: modulation of the System Xc-/GSH/GPX4 axis to alleviate oxidative stress and ferroptosis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1552228
Original Research
Accepted on 24 Feb 2025
Isobavachalcone ameliorates Alzheimer disease pathology by autophagy-mediated clearance of amyloid beta and inhibition of NLRP3 inflammasome in primary astrocytes and 5x-FAD mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1525364
Original Research
Accepted on 24 Feb 2025
Antidepressants on Stroke Outcomes Assessing the Effects of Antidepressant Use on Stroke Recurrence and Related Outcomes in Ischemic Stroke Patients: A Propensity Score Matched Analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1558703
Review
Published on 24 Feb 2025
Ferroptosis, pathogenesis and therapy in AS co-depression disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516601
- 148 views
Original Research
Accepted on 21 Feb 2025
Levodopa-induced motor complications associated with benserazide and carbidopa in Parkinson's disease: A disproportionality analysis of the FAERS database
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1529932
- 609 views
Original Research
Accepted on 20 Feb 2025
Neuroprotective effects of arctigenin on cerebral ischemia-reperfusion injury in rats via the EPO/EPOR-JAK2-STAT5 signaling pathway
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1503971
Review
Published on 20 Feb 2025
Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1528544
- 521 views
Systematic Review
Published on 19 Feb 2025
New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke prevention in East Asian populations: a systematic review and meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533674
- 161 views
Original Research
Accepted on 18 Feb 2025
A Real-World Safety Surveillance Study of Aducanumab Through the FDA Adverse Event Reporting System (FAERS)
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522058
Review
Accepted on 17 Feb 2025
Histone deacetylases: the critical enzymes for microglial activation involved in neuropathic pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1515787
Original Research
Accepted on 17 Feb 2025
α-Bisabolol Alleviates Doxorubicin-Induced Cognitive Dysfunction in Rats Via Enhancing the Hippocampal BDNF/TrKB Signaling and Inhibiting Neuroinflammation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1549009